Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
“the quality of life and emotional well-being of some cancer patients undergoing radiation therapy and chemotherapy increased when they were visited by a therapy dog during their treatment”
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have found that defects in how cells are squeezed out of overcrowded tissue ...
A similar revolution has taken place in immunology, which focuses on helping the immune system fight infection and other diseases, including cancer.
The human immune system creates autoantibodies when it recognizes a cancerantigen. Apifiny (pronounced eh-pif'-a-nee) is a non-PSA ...
Scientists who study cancer and viruses say that figure may be more than ... Whenever a bacteria or virus enters the body, the immune system uses ...
Sip on green/chamomile tea: There is enough proof that green tea and chamomile tea can strengthen the immune system. Green tea/ chamomile tea ...
Additionally, we suspect that SABR may be able to assist in kick-starting the patient's immune system into fighting any remaining cancer cells, and we ...
New data provide evidence that Hexvix can improve the overall survival in bladder cancer patients Source text for Eikon: Further company coverage: ...
There are today at least 110 targeted molecular therapies known to affect more than 216 specific intracellular signaling pathways for the treatment of ...
Bladder cancer is the most common malignant tumor of the urinary system and it is a heterogeneous disease with both superficial and invasive growth.
We are assessing the toxicology, regulatory, and clinical steps necessary to move entolimod forward in a non-invasive bladder cancer indication.".
Inovio's DNA-based immunotherapy technology uniquely activates highly potent antigen-specific killer T cells targeting a specific cancer in the body.
PARIS, FRANCE, January 29th2015: OSE Pharma, a biotechnology company developing T-cell specific immunotherapy, and Simbec-Orion, a leading ...
FDA Approves Ibrutinib for Waldenström Macroglobulinemia
The FDA has expanded the approved use of ibrutinib (Imbruvica) to include patients with Waldenström macroglobulinemia, a rare lymphoma.
The FDA has expanded the approved use of ibrutinib (Imbruvica) to include patients with Waldenström macroglobulinemia, a rare lymphoma.
Adoption of Hypofractionated Radiotherapy in Early-Stage Breast Cancer
The benefit of hypofractionated radiotherapy for women receiving breast-conserving therapy for early-stage breast cance
The benefit of hypofractionated radiotherapy for women receiving breast-conserving therapy for early-stage breast cance
Latest News January 29, 2015
MBI Boosts Cancer Detection in Patients With Dense Breasts
Adding molecular breast imaging to mammography resulted in a fourfold increase in invasive breast cancer detection rates in women with dense breasts.
Adding molecular breast imaging to mammography resulted in a fourfold increase in invasive breast cancer detection rates in women with dense breasts.
Increased Coffee Intake Linked With Lower Melanoma Risk
Consumption of four or more cups of caffeinated coffee per day was associated with a 20% decreased risk for malignant melanoma, according to a recent study.
Consumption of four or more cups of caffeinated coffee per day was associated with a 20% decreased risk for malignant melanoma, according to a recent study.
Birth Control Pill Linked to Increased Glioma Risk
A history of hormonal contraceptive use in younger women for 5 years or more was found to be associated with a possible increased risk of glioma.
A history of hormonal contraceptive use in younger women for 5 years or more was found to be associated with a possible increased risk of glioma.
RNA Test for HPV Helps Stratify Cervical Cancer Risk
A test for dangerous strains of high-risk HPV using messenger RNA was shown to be reliable and effective for cervical cancer risk stratification.
A test for dangerous strains of high-risk HPV using messenger RNA was shown to be reliable and effective for cervical cancer risk stratification.
Smokers Have Worse Prostate Cancer Outcomes
Prostate cancer patients who smoke may be more susceptible to complications from treatment, and have increased risk of side effects and disease recurrence.
Prostate cancer patients who smoke may be more susceptible to complications from treatment, and have increased risk of side effects and disease recurrence.
Breast Cancer Patients Often Don't Know Details of Their Tumor
Many women with breast cancer do not understand the details of their tumor characteristics or how they relate to specific treatment options, according to a new study.
Many women with breast cancer do not understand the details of their tumor characteristics or how they relate to specific treatment options, according to a new study.
Veliparib Trial Fails to Improve Outcomes in Ovarian Cancer
Adding the PARP inhibitor veliparib to cyclophosphamide did not improve response rates or progression-free survival in ovarian cancer.
Adding the PARP inhibitor veliparib to cyclophosphamide did not improve response rates or progression-free survival in ovarian cancer.
Adding Cetuximab to FOLFIRI Best in RAS Wild-Type Colorectal Cancer
Adding cetuximab to FOLFIRI resulted in improvements in survival and objective response in patients with KRAS codon exon 2 wild-type metastatic colorectal cancer.
Adding cetuximab to FOLFIRI resulted in improvements in survival and objective response in patients with KRAS codon exon 2 wild-type metastatic colorectal cancer.
MRD Identifies Relapse Risk in Pediatric ALL Post-Transplant
In a recent study of pediatric ALL, minimal residual disease was able to predict patients who were at increased risk for relapse post-allogeneic stem cell transplantation.
In a recent study of pediatric ALL, minimal residual disease was able to predict patients who were at increased risk for relapse post-allogeneic stem cell transplantation.
Socioeconomic Factors Affecting Use of Radiation Therapy in Hodgkin Lymphoma
Socioeconomic factors are reducing the use of combined-modality treatment for early-stage Hodgkin lymphoma, despite its association with increased survival.
Socioeconomic factors are reducing the use of combined-modality treatment for early-stage Hodgkin lymphoma, despite its association with increased survival.
Genetic Variant Affects Treatment Intolerance in Pediatric ALL
Using genome-wide association studies, researchers have identified a germline variant that is associated with intolerance to mercaptopurine in pediatric ALL.
Using genome-wide association studies, researchers have identified a germline variant that is associated with intolerance to mercaptopurine in pediatric ALL.
Myeloma Working Group Releases Statement on Use of MRI
The International Myeloma Working Group recently published a series of consensus statements discussing the use of MRI in the treatment of multiple myeloma.
The International Myeloma Working Group recently published a series of consensus statements discussing the use of MRI in the treatment of multiple myeloma.
ASCO GI Symposium
TKI Famitinib Delays Progression in Advanced Colorectal Cancer
The TKI famitinib was associated with a significant PFS improvement in metastatic colorectal cancer patients, according to the results of a phase II study.
The TKI famitinib was associated with a significant PFS improvement in metastatic colorectal cancer patients, according to the results of a phase II study.
NAPOLI-1: MM-398 Combo Shows Benefit in Metastatic Pancreatic Cancer
Combining MM-398 with 5-FU/leucovorin chemotherapy in metastatic pancreatic cancer patients resulted in improved survival compared with 5-FU/leucovorin alone.
Combining MM-398 with 5-FU/leucovorin chemotherapy in metastatic pancreatic cancer patients resulted in improved survival compared with 5-FU/leucovorin alone.
Watch-and-Wait Surgical Approach Safe for Some Rectal Cancers
Rectal cancer patients who completed neoadjuvant therapy with a clinical complete response had similar 4-year survival rates as patients who opted for surgery.
Rectal cancer patients who completed neoadjuvant therapy with a clinical complete response had similar 4-year survival rates as patients who opted for surgery.
Baseline AFP Levels Affect Ramucirumab Benefit in HCC
Hepatocellular carcinoma patients with baseline alpha-fetoprotein (AFP) levels greater than 400 ng/mL may derive greater benefit from second-line ramucirumab.
Hepatocellular carcinoma patients with baseline alpha-fetoprotein (AFP) levels greater than 400 ng/mL may derive greater benefit from second-line ramucirumab.
Second-Line Ramucirumab Plus Chemotherapy Improved Survival in Metastatic Colorectal Cancer
The addition of ramucirumab to second-line FOLFIRI resulted in a delay in disease progression and improved survival in metastatic colorectal cancer patients.
The addition of ramucirumab to second-line FOLFIRI resulted in a delay in disease progression and improved survival in metastatic colorectal cancer patients.
Cancer News in Science Daily
A gene that is associated with lung cancer has been identified by researchers. Through whole exome sequencing, they identified a link between a mutation in PARK2, a gene associated with early-onset Parkinson's disease, and familial lung cancer.
People who worry about cancer are more likely to want to get screened for colon cancer, but feeling uncomfortable at the thought of cancer makes them less likely to actually go for the test, finds new research.
Inhibition of Sirtuin1 protein may be a future treatment option for metastatic Ewing sarcoma, researchers report. Ewing's sarcoma is the second most common bone cancer and affects children and adolescents. Currently, if diagnosed in time and there is no metastasis, it can be cured in 80% of cases but between 25% and 30% of cases are diagnosed when there is already metastasized, at which low survival to 30 %.
Tambahkan Komentar